APOB and familial hyperaldosteronism: Despite these limitations, our meta-analysis proves that PCSK9-mAbs exert significant protection from FH, including decreasing the plasma levels of LDL-C and Lp(a), TC, TG, and Apo-B and increasing the plasma levels of HDL-C and Apo-A1.